Sheila M. Grant
Chief Tech/Sci/R&D Officer bij XENON PHARMACEUTICALS INC.
Profiel
Sheila M.
Grant is currently the Executive VP-Research & Development Operations at Xenon Pharmaceuticals, Inc. Prior to her current position, she served as the Chief Operating Officer at Correvio Pharma Corp.
from 2013 to 2020.
Additionally, she worked as a Consultant at Twinstrand Therapeutics, Inc. Ms. Grant holds an MBA from Simon Fraser University, a graduate degree from the London School of Hygiene & Tropical Medicine, and an undergraduate degree from the University of Essex.
Actieve functies van Sheila M. Grant
| Bedrijven | Functie | Begin |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01-08-2020 |
Eerdere bekende functies van Sheila M. Grant
| Bedrijven | Functie | Einde |
|---|---|---|
| CORREVIO PHARMA CORP. | Chief Operating Officer | 27-05-2020 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Corporate Officer/Principal | - |
Opleiding van Sheila M. Grant
| Simon Fraser University | Masters Business Admin |
| London School of Hygiene & Tropical Medicine | Graduate Degree |
| University of Essex | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
